Literature DB >> 9122262

Irreversible antagonism of 5HT2c receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).

Y G Ni1, N Camacho, R Miledi.   

Abstract

To determine if N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ), a carboxyl group activating agent, can inactivate 5HT2c receptors, we have examined the effects of EEDQ on 5HT2c receptor-mediated responses to 5-hydroxytryptamine (5HT) in Xenopus oocytes, and on the binding of [3H]5HT to 5HT2c receptors in transfected HeLa cells. In oocytes expressing rat 5HT2c receptors, EEDQ inhibited the 5HT2c receptor-mediated Cl- currents; and the response did not recover more than 24 h after removal of the EEDQ. To see if this effect of EEDQ was on the receptor itself, the binding of 5HT to 5HT2c receptors was studied in transfected HeLa cells. EEDQ decreased the specific binding of [3H]5HT to 5HT2c receptors. At approximately 22 degrees C, incubating the membranes with 2 x 10(-4) M EEDQ for 1 h caused a 40% decrease in the Bmax, without changing the K(d). At 37 degrees C, the same treatment with EEDQ blocked [3H]5HT binding completely. Half-maximal inhibition occurred at 5 microM EEDQ at both temperatures, and washing for 1.5 h did not restore the binding, suggesting that the inactivation of 5HT2c receptor binding was practically irreversible. Results from both systems showed clearly that EEDQ is an irreversible antagonist of 5HT2c receptors and therefore can be used for many studies of this receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9122262      PMCID: PMC20155          DOI: 10.1073/pnas.94.6.2715

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  The mechanism of irreversible adrenergic blockade by N-carbethoxydihydroquinolines--model studies with typical serine hydrolases.

Authors:  B Belleau; V DiTullio; D Godin
Journal:  Biochem Pharmacol       Date:  1969-05       Impact factor: 5.858

2.  A calcium-dependent transient outward current in Xenopus laevis oocytes.

Authors:  R Miledi
Journal:  Proc R Soc Lond B Biol Sci       Date:  1982-07-22

3.  Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.

Authors:  E Meller; K Bohmaker; M Goldstein; A J Friedhoff
Journal:  J Pharmacol Exp Ther       Date:  1985-06       Impact factor: 4.030

4.  Guanine nucleotide regulation of a mammalian myocardial muscarinic receptor system. Evidence for homo- and heterotropic cooperativity in ligand binding analyzed by computer-assisted curve fitting.

Authors:  R Mattera; B J Pitts; M L Entman; L Birnbaumer
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

5.  Chloride current induced by injection of calcium into Xenopus oocytes.

Authors:  R Miledi; I Parker
Journal:  J Physiol       Date:  1984-12       Impact factor: 5.182

6.  In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery.

Authors:  G Battaglia; A B Norman; P L Newton; I Creese
Journal:  J Neurochem       Date:  1986-02       Impact factor: 5.372

7.  Serotonin 5-HT2C receptor stimulates cyclic GMP formation in choroid plexus.

Authors:  M J Kaufman; P R Hartig; B J Hoffman
Journal:  J Neurochem       Date:  1995-01       Impact factor: 5.372

8.  Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.

Authors:  A B Norman; I Creese
Journal:  Mol Pharmacol       Date:  1986-08       Impact factor: 4.436

9.  A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover.

Authors:  P J Conn; E Sanders-Bush; B J Hoffman; P R Hartig
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

10.  Cholinergic and catecholaminergic receptors in the Xenopus oocyte membrane.

Authors:  K Kusano; R Miledi; J Stinnakre
Journal:  J Physiol       Date:  1982-07       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.